Pimavanserin for the Treatment of Alzheimer’s Disease Psychosis: An Evaluation of the Clinical Importance of Efficacy Results

Clive Ballard, Jeffrey Cummings, Pierre N Tariot, Sanjeev Pathak, Bruce Coate, Srdjan Stankovic
doi: https://doi.org/10.1101/2022.08.11.22278482

Article usage

Article usage: August 2022 to January 2025

AbstractFullPdf
Aug 20222961629
Sep 2022135217
Oct 2022140519
Nov 2022159713
Dec 20229629
Jan 202375210
Feb 20232048
Mar 20234986
Apr 202328107
May 202322115
Jun 202319106
Jul 20231383
Aug 202323206
Sep 2023271411
Oct 20231683
Nov 202312134
Dec 20231452
Jan 20241496
Feb 202416199
Mar 202415133
Apr 2024222510
May 202415204
Jun 202420205
Jul 202416812
Aug 202422118
Sep 202427811
Oct 20248143
Nov 20241938
Dec 2024627
Jan 202522513
Back to top
Posted August 12, 2022.
Download PDF
Data/Code
Email
Pimavanserin for the Treatment of Alzheimer’s Disease Psychosis: An Evaluation of the Clinical Importance of Efficacy Results
Clive Ballard, Jeffrey Cummings, Pierre N Tariot, Sanjeev Pathak, Bruce Coate, Srdjan Stankovic
medRxiv 2022.08.11.22278482; doi: https://doi.org/10.1101/2022.08.11.22278482
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area